Document Detail


Outcome of second line therapy in rheumatoid arthritis.
MedLine Citation:
PMID:  7864689     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To study the functional outcome in patients with rheumatoid arthritis (RA) who tolerate second line drug therapy for five years. METHODS: We enrolled into prospective controlled trials, 190 patients with rheumatoid arthritis who tolerated 'disease modifying' antirheumatic drug therapy for five years. Demographic data were recorded. Disease activity was measured every six months for two years and annually thereafter, using clinical and laboratory variables. Patient function was measured using the modified Health Assessment Questionnaire. The change in each variable was analysed using paired Wilcoxon tests. RESULTS: Patient function improved significantly compared with baseline. The improvement was maximal after one to two years, and thereafter function started to decline slowly. After five years of treatment the patients' function was still significantly better than before treatment had started. There were highly significant improvements in all variables measured to assess disease activity, which remained well controlled throughout the five year period. CONCLUSION: Good control of disease activity and improved function can be achieved long term in approximately 30% of RA patients treated with injectable gold, sulphasalazine or penicillamine.
Authors:
D R Porter; I McInnes; J Hunter; H A Capell
Related Documents :
18976749 - Methotrexate therapy for cesarean section scar pregnancy with and without suction curet...
23230099 - Primary prevention of macroangiopathy in patients with short-duration type 2 diabetes b...
11791759 - Long-term therapy with plasma exchange in systemic sclerosis: effects on laboratory mar...
17332979 - Anti-tnf therapy in the treatment of ankylosing spondylitis: the finnish experience.
16127769 - Rheumatoid factor is a marker of disease severity in korean rheumatoid arthritis.
23305609 - The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.
15272129 - Individual patient data meta-analysis of randomized controlled trials of community occu...
11306879 - Is there a relationship between the amount of tissue removed at transurethral resection...
22017979 - Posterior glottic gap and age as factors predicting voice outcome of injection laryngop...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Annals of the rheumatic diseases     Volume:  53     ISSN:  0003-4967     ISO Abbreviation:  Ann. Rheum. Dis.     Publication Date:  1994 Dec 
Date Detail:
Created Date:  1995-03-21     Completed Date:  1995-03-21     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  0372355     Medline TA:  Ann Rheum Dis     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  812-5     Citation Subset:  IM    
Affiliation:
Centre for Rheumatic Diseases, Glasgow Royal Infirmary, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy*
Humans
Middle Aged
Organogold Compounds
Penicillamine / therapeutic use*
Prospective Studies
Sulfasalazine / therapeutic use*
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antirheumatic Agents; 0/Organogold Compounds; 52-67-5/Penicillamine; 599-79-1/Sulfasalazine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Musculoskeletal disorders and disability in persons aged 85 and over: a community survey.
Next Document:  Increment of CD8S6F1 cells in synovial fluid from patients with rheumatoid arthritis.